Paraneoplastic encephalitis associated with myasthenia gravis and malignant thymoma. 2012

Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

We present a patient with type B2 thymoma (World Health Organization Thymoma Classification) with the complications of anti-muscle acetylcholine receptor antibody-positive myasthenia gravis and anti-voltage-gated potassium channel antibodies associated with paraneoplastic encephalitis. A timing difference between the onset of these neurological disorders and a dissociation of clinical symptoms was observed during the disease. This report alerts clinicians that long-term follow-up is needed where patients have a residual thymoma and attention should be paid to other concomitant autoimmune disorders.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013945 Thymoma A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed) Carcinoma, Thymic,Carcinomas, Thymic,Thymic Carcinoma,Thymic Carcinomas,Thymomas
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus
D020361 Paraneoplastic Syndromes, Nervous System Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. (Intern Med 1996 Dec;35(12):925-9) Paraneoplastic Autonomic Dysfunction,Paraneoplastic Encephalomyelitis,Autonomic Dysfunction, Paraneoplastic,Nervous System Paraneoplastic Syndromes,Paraneoplastic Neurologic Syndromes,Autonomic Dysfunctions, Paraneoplastic,Encephalomyelitis, Paraneoplastic,Neurologic Syndrome, Paraneoplastic,Neurologic Syndromes, Paraneoplastic,Paraneoplastic Autonomic Dysfunctions,Paraneoplastic Encephalomyelitides,Paraneoplastic Neurologic Syndrome,Syndrome, Paraneoplastic Neurologic,Syndromes, Paraneoplastic Neurologic

Related Publications

Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
November 2009, Archives of neurology,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
July 2017, Proceedings (Baylor University. Medical Center),
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
September 1955, American review of tuberculosis,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
August 2010, Autoimmunity,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
May 2017, Neuromuscular disorders : NMD,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
September 2023, Journal of clinical neuromuscular disease,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
June 2008, Hematology/oncology clinics of North America,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
May 1954, American practitioner and digest of treatment,
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
January 2008, Internal medicine (Tokyo, Japan),
Yu Miyazaki, and Masaaki Hirayama, and Hirohisa Watanabe, and Noriyasu Usami, and Kohei Yokoi, and Osamu Watanabe, and Gen Sobue
October 1958, La Presse medicale,
Copied contents to your clipboard!